| Product Code: ETC6741192 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China import shipments of deferasirox were primarily sourced from Puerto Rico, Metropolitan France, Germany, Spain, and Italy, indicating diverse geographical supply sources. The high Herfindahl-Hirschman Index (HHI) suggests a concentrated market landscape. Despite a negative compound annual growth rate (CAGR) of -2.06% from 2020 to 2024, the sharp decline in growth rate (-26.63%) from 2023 to 2024 raises concerns. Monitoring market dynamics and factors influencing this downward trend will be crucial for stakeholders in the deferasirox import industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Deferasirox Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Deferasirox Market Revenues & Volume, 2021 & 2031F |
3.3 China Deferasirox Market - Industry Life Cycle |
3.4 China Deferasirox Market - Porter's Five Forces |
3.5 China Deferasirox Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Deferasirox Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Deferasirox Market Revenues & Volume Share, By Population Type, 2021 & 2031F |
3.8 China Deferasirox Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 China Deferasirox Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Deferasirox Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of iron overload disorders in China |
4.2.2 Growing awareness and diagnosis of thalassemia and other blood disorders |
4.2.3 Rising healthcare expenditure and improved access to healthcare facilities in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 Competition from alternative iron chelation therapies |
4.3.3 Limited reimbursement policies for deferasirox in certain regions of China |
5 China Deferasirox Market Trends |
6 China Deferasirox Market, By Types |
6.1 China Deferasirox Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Deferasirox Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Deferasirox Market Revenues & Volume, By 500mg, 2021- 2031F |
6.1.4 China Deferasirox Market Revenues & Volume, By 250mg, 2021- 2031F |
6.1.5 China Deferasirox Market Revenues & Volume, By 215 mg, 2021- 2031F |
6.2 China Deferasirox Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Deferasirox Market Revenues & Volume, By ?-thalassemia, 2021- 2031F |
6.2.3 China Deferasirox Market Revenues & Volume, By Myelodysplastic Syndromes (MDS), 2021- 2031F |
6.2.4 China Deferasirox Market Revenues & Volume, By Sickle Cell Disease (SCD), 2021- 2031F |
6.2.5 China Deferasirox Market Revenues & Volume, By Aplastic Anemia (AA), 2021- 2031F |
6.2.6 China Deferasirox Market Revenues & Volume, By Diamond-Blackfan Anemia (DBA), 2021- 2031F |
6.3 China Deferasirox Market, By Population Type |
6.3.1 Overview and Analysis |
6.3.2 China Deferasirox Market Revenues & Volume, By Adults, 2021- 2031F |
6.3.3 China Deferasirox Market Revenues & Volume, By Paediatric, 2021- 2031F |
6.4 China Deferasirox Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 China Deferasirox Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.3 China Deferasirox Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 China Deferasirox Market Revenues & Volume, By Home Care, 2021- 2031F |
6.5 China Deferasirox Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Deferasirox Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 China Deferasirox Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 China Deferasirox Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 China Deferasirox Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 China Deferasirox Market Import-Export Trade Statistics |
7.1 China Deferasirox Market Export to Major Countries |
7.2 China Deferasirox Market Imports from Major Countries |
8 China Deferasirox Market Key Performance Indicators |
8.1 Patient adherence rate to deferasirox treatment |
8.2 Number of healthcare facilities offering deferasirox treatment |
8.3 Rate of new product development and innovation in the iron chelation therapy market in China |
9 China Deferasirox Market - Opportunity Assessment |
9.1 China Deferasirox Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Deferasirox Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Deferasirox Market Opportunity Assessment, By Population Type, 2021 & 2031F |
9.4 China Deferasirox Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 China Deferasirox Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Deferasirox Market - Competitive Landscape |
10.1 China Deferasirox Market Revenue Share, By Companies, 2024 |
10.2 China Deferasirox Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here